Table of Contents
ISRN Hematology
Volume 2014 (2014), Article ID 547914, 4 pages
http://dx.doi.org/10.1155/2014/547914
Research Article

The Problem of Anaemia in Patients with Colorectal Cancer

Division of Surgery and Interventional Science, University College London, 4th Floor, 74 Huntley Street, London WC1E 6AU, UK

Received 23 October 2013; Accepted 22 December 2013; Published 12 February 2014

Academic Editors: Z. Duan and V. Georgoulias

Copyright © 2014 M. Khanbhai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. S. Tchekmedyian, “Anemia in cancer patients: significance, epidemiology, and current therapy,” Oncology, vol. 16, no. 9, supplement 10, pp. 17–24, 2002. View at Google Scholar · View at Scopus
  2. H. Ludwig, S. Van Belle, P. Barrett-Lee et al., “The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients,” European Journal of Cancer, vol. 40, no. 15, pp. 2293–2306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Caro, M. Salas, A. Ward, and G. Goss, “Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review,” Cancer, vol. 91, no. 12, pp. 2214–2221, 2001. View at Google Scholar
  4. M. Zacharakis, I. D. Xynos, A. Lazaris et al., “Predictors of survival in stage IV metastatic colorectal cancer,” Anticancer Research, vol. 30, no. 2, pp. 653–660, 2010. View at Google Scholar · View at Scopus
  5. G. D. Demetri, “Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy,” British Journal of Cancer, vol. 84, no. 1, pp. 31–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Goodman and T. T. Irvin, “Delay in the diagnosis and prognosis of carcinoma of the right colon,” British Journal of Surgery, vol. 80, no. 10, pp. 1327–1329, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Spivak, P. Gascón, and H. Ludwig, “Anemia management in oncology and hematology,” The Oncologist, vol. 14, pp. 43–56, 2009. View at Google Scholar · View at Scopus
  8. A. Shander, K. Knight, R. Thurer, J. Adamson, and R. Spence, “Prevalence and outcomes of anemia in surgery: a systematic review of the literature,” American Journal of Medicine, vol. 116, no. 7, pp. 58–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Napolitano, “Perioperative anemia,” Surgical Clinics of North America, vol. 85, no. 6, pp. 1215–1227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Carson, A. Duff, R. M. Poses et al., “Effect of anaemia and cardiovascular disease on surgical mortality and morbidity,” The Lancet, vol. 348, no. 9034, pp. 1055–1060, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kulier, J. Levin, R. Moser et al., “Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery,” Circulation, vol. 116, no. 5, pp. 471–479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Cladellas, J. Bruguera, J. Comìn et al., “Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement?” European Heart Journal, vol. 27, no. 9, pp. 1093–1099, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Dunne, D. Malone, J. K. Tracy, C. Gannon, and L. M. Napolitano, “Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery,” Journal of Surgical Research, vol. 102, no. 2, pp. 237–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Gombotz, P. H. Rehak, A. Shander, and A. Hofmann, “Blood use in elective surgery: the Austrian benchmark study,” Transfusion, vol. 47, no. 8, pp. 1468–1480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. J. Littlewood, E. Bajetta, J. W. R. Nortier, E. Vercammen, and B. Rapoport, “Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial,” Journal of Clinical Oncology, vol. 19, no. 11, pp. 2865–2874, 2001. View at Google Scholar · View at Scopus
  16. G. Thomas, “The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience,” Seminars in Oncology, vol. 28, no. 2, supplement 8, pp. 60–65, 2001. View at Google Scholar · View at Scopus
  17. M. Tampellini, A. Saini, I. Alabiso et al., “The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients,” British Journal of Cancer, vol. 95, no. 1, pp. 13–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Vaupel, “Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis,” Oncologist, vol. 13, no. 3, pp. 21–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. Alter and H. G. K. Harvey G. Klein, “The hazards of blood transfusion in historical perspective,” Blood, vol. 112, no. 7, pp. 2617–2626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kleinman, P. Chan, and P. Robillard, “Risks associated with transfusion of cellular blood components in Canada,” Transfusion Medicine Reviews, vol. 17, no. 2, pp. 120–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. Wallis, “Progress in TRALI,” Transfusion Medicine, vol. 18, no. 5, pp. 273–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Brand, “Immunological aspects of blood transfusions,” Transplant Immunology, vol. 10, no. 2-3, pp. 183–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. E. C. Vamvakas and M. A. Blajchman, “Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention,” Blood, vol. 113, no. 15, pp. 3406–3417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Atzil, M. Arad, A. Glasner et al., “Blood transfusion promotes cancer progression: a critical role for aged erythrocytes,” Anesthesiology, vol. 109, no. 6, pp. 989–997, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Ojima, M. Iwahashi, M. Nakamori et al., “Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy,” Journal of Gastrointestinal Surgery, vol. 13, no. 10, pp. 1821–1830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Spahn, H. Moch, A. Hofmann, and J. P. Isbister, “Patient blood management: the pragmatic solution for the problems with blood transfusions,” Anesthesiology, vol. 109, no. 6, pp. 951–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Segal, E. Blasco-Colmenares, E. J. Norris, and E. Guallar, “Preoperative acute normovolemic hemodilution: a meta-analysis,” Transfusion, vol. 44, no. 5, pp. 632–644, 2004. View at Publisher · View at Google Scholar · View at Scopus